News

ALLG continues to work towards a cure for blood cancer through our strong collaborations with global cancer groups & innovative treatments.

ALLG HD10 & GHSG HD21 features on ABC Radio's Health Report.

Our latest community news, ALLG News Edition 9, is now available! Download a copy to read about our highly successful blood cancer clinical trials and much more.

World Cancer Research Day is an essential day that raises awareness of how important research is to making a difference for patients and facilitating equitable access to cutting-edge treatments [...]

ALLG trial participant and consumer representative, Emma Priest, has featured in the Herald Sun in an article titled "Melbourne nurse Emma Priest's battle to beat cancer in a clinical trial."

ALLG, in its 51st year, continue to have a global impact with its clinical trial research as we aim to find a cure for blood cancer.

ALLG welcomes the release of the Health Technology Assessment (HTA) Review by the Albanese Government.

ALLG supports Blood Cancer Awareness Month this September. Help support clinical trials as we aim to deliver better treatments, better lives for blood cancer patients.

Our latest community news, ALLG News Edition 8, is now available! Download a copy to read about our highly successful ALL09 trial, ALLG members on the international stage and much more!

ALLG Member, Associate Professor Matthew Greenwood, received international recognition at the EHA conference for breakthrough research results that pave the way to change treatment for AYA [...]

ALLG are saddened to announce that our respected colleague and friend Professor Paul Vincent passed away on 7 June 2024 at Concord Hospital in Sydney.

ALLG recently launched its Research Report 2023. This report demonstrates how ALLG develops cancer treatments to improve survival rates & quality of life for patients with blood cancer.

Australia’s Blood Cancer Taskforce has launched Five New Optimal Care Pathways for blood cancer treatment & care, setting the national standard of cancer care.

The annual Fellowship Program, in partnership with the HSANZ, will provide early-career researchers a pathway to a career in clinical trial research by engaging with ALLG trials.

Our latest community news, ALLG News Edition 7, is now available! Download a copy to read about our work to progress blood cancer treatments through impactful and innovative clinical trials using [...]

A/Prof Anoop received $827,000 for the MDS MESSAGE clinical trial under the MRFF Early to Mid-Career Research Grant Opportunity. Discover more about ALLG’s blood cancer research.

ALLG are saddened to announce that our respected friend & colleague Doctor Kenneth Romeril passed away peacefully, surrounded by family and loved ones, on 8 February 2024.

ALLG’s clinical trial on myeloproliferative neoplasms aimed at understanding their complexity & the importance of early diagnosis in cancer treatments.

In ALLG News Edition 6, you can read about progress in blood cancer treatment, the future of clinical trials, the role trial coordinators play in improving cancer care, and learn the latest in [...]

During the October 2023 Scientific Meeting, ALLG welcomed our five new Life Members: Professor Mark Hertzberg, Professor Paula Marlton, Michele Gambrill, Professor Andrew Grigg and Professor [...]

Life Member and Order of Australia recipient, Professor Mark Hertzberg was recently appointed as our new Board Director.

On Friday 27 October we wrapped up our bumper 50th Anniversary ALLG Scientific Meeting.

We’ve been eagerly awaiting the chance to announce who has been inducted into the ALLG Annual Hall of Fame this year. At our 50th anniversary Gala dinner last night at Crown Sydney, we [...]

You could say that this year’s ALLG October Scientific Meeting week has been 50 years in the making. Tomorrow, we are looking forward to welcoming record number of ALLG Members to open this very [...]

It’s a very special year at the ALLG. Our collaborative success in clinical trials has laid the foundations for a brighter future for blood cancer patients for over 50 years. There’s a lot to [...]

Calling blood cancer patients and carers in Sydney! Would you like to know more from the experts about wellbeing throughout your treatment journey? Or hear how clinical trials can help you?

September is Blood Cancer Month. You can read about ALLG's "5 decades of impact" in blood cancer clinical trials, and the "best results we have ever seen" in Advanced Hodgkin lymphoma from one of [...]

The ALLG's Laboratory Science research is helping determine which patients benefit from targeted therapy for their blood cancer. You can read about this and more in our latest quarterly [...]

The HeSANDA platform is a catalogue of research metadata from clinical trials conducted across Australia that enables researchers to access and share data from health studies. Led by the [...]

Congratulations to ALLG Life Member Dr Ruth Spearing who has been honoured in the 2023 King's Birthday New Zealand and Coronation Honours! Ruth has been made a Companion of the New Zealand Order [...]

Two ALLG clinical trials, ALL08 BLAM and NHL29 IRIC have been accepted as abstracts with poster presentations at prestigious European scientific conferences.

ALLG has featured in The Limbic with our Scientific Advisory Committee Chair, Prof Judith Trotman, interviewed about our five decades of impact.

It's our pleasure to share with you the third Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

Sir Sam Neill, New Zealand (NZ) actor and blood cancer survivor supports the ALLG’s concerns of proposed NZ bill affecting clinical trials.

ALLG has featured in the Herald Sun and The Advertiser newspapers with "World first cancer trial" about a novel way to identify and treat patients with acute myeloid leukaemia (AML) before they [...]

Prof Hang Quach, Chair of ALLG's Myeloma Scientific Working Party talks about clinical trials in myeloma for better treatments…better lives.